Priorities Agreed For WSAVA Foundation's AFSCAN Initiative
8 years agoMembers of the AFSCAN Project Board and national delegates at the meeting in Nairobi. The World Small Animal Veterinary Association (WSAVA) Foundation took the first steps towards delivering its African Small Companion Animal Network (AFSCAN) project at a recent meeting in Nairobi, Kenya, during which it identified the priority needs of small companion animal veterinarians in Africa and agreed a roadmap of projects through which AFSCAN can help to meet them. The WSAVA Foundation funds improvements in the veterinary care of companion animals worldwide through science and education. It unveiled its ground-breaking scheme, AFSCAN, at BSAVA Congress earlier this year. AFSCAN aims to advance standards of veterinary care across Africa through facilitating the creation of a sustainable network of companion animal veterinarians, associations and specialist groups in Sub-Saharan Africa. All of its work will have a focus on One Health. During the three day visit to Nairobi, from 18-20 June, the AFSCAN Project Board met delegates from Kenya, Uganda, Namibia and Nigeria at the Regional Office of the International Organisation for Animal Health (OIE). It also visited the veterinary school at the University of Nairobi and met the Dean of the School and members of academic staff, a student delegation and representatives from the One Health Central and Eastern Africa (OHCEA) Consortium. The AFSCAN Project Board is chaired by Dr Gabriel Varga, President of the WSAVA Foundation and includes Professor Michael Day (University of Bristol, UK, and WSAVA Foundation); Dr Theo Kanellos and Mr Greg Andrews (Zoetis); Dr Remo Lobetti (referral practitioner, South Africa) and Dr Alex Thiermann (OIE). Commenting, Dr Varga said: “Working with the national delegates, we identified a range of projects to support small companion animal veterinarians as they work towards establishing the national associations that will become new members of the WSAVA family. AFSCAN support will take the form of specific sub-projects providing new opportunities in veterinary continuing education, clinical veterinary research, infectious disease surveillance and control of canine rabies. "For example, African practitioners will be given access to the on-line educational content provided by the North American Veterinary Community (NAVC) Vetfolio initiative with access to refurbished computers from the UK charity Computers for Africa. Academic practitioners will also be encouraged to apply for AFSCAN funding for targeted research projects linking African universities with partner institutions in other countries. He continued: "We will meet again during WSAVA World Congress in Cape Town, South Africa, in September and will be joined by additional delegates from Angola, Ethiopia, Sudan and Tanzania. "AFSCAN will assist small companion animal veterinarians in the creation of national associations because it is the creation of these associations leading, as they do, to enhancements in collaboration, training and best practice sharing, which has proved pivotal in driving enhancements in standards of veterinary care in other regions of the world. Through AFSCAN we have a real opportunity to help advance the veterinary profession across Africa and, in so doing, improve the lives of millions of animals and humans." The AFSCAN project runs under the auspices of the WSAVA Foundation with Zoetis as a major supporter. Other supporters and sponsors of AFSCAN include the OIE, the NAVC and veterinary digital content provider Vetstream; veterinary charity Worldwide Veterinary Services and its Mission Rabies Project; veterinary equipment supplier Kruuse; the Morris Animal Foundation; healthcare advertising agency Circa Health; the University of Veterinary Medicine in Kosice and the WSAVA.
28th July, 2014 11h00
- Willows at the forefront of TKR care across UK and Europe
- New Leadon Vale website highlights stem cell expertise
- Somerset&#39;s Cave Veterinary Specialists invests £1.2m in class-leading MRI scanner
- Nettex Equine help horses perform, look and feel their best with new V.I.P range
- Systematic review does not support use of angiotensin-converting enzyme inhibitors in dogs with preclinical myxomatous mitral disease and cardiomegaly